US Karate athlete gets nine months for LGD-4033October 01, 2019
USADA announced today that Joane Orbon, of San Jose, Calif., an athlete in the sport of karate, has accepted a nine-month sanction after testing positive for a prohibited substance from a contaminated supplement.
Orbon, 24, tested positive for di-hydroxy-LGD-4033, a metabolite of LGD-4033, as the result of an in‐competition urine sample she provided at the Senior Team Trials on January 19, 2019. LGD‐4033 is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policies, and the World Karate Federation Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
In the Anti-Doping Database we have registered 11 athletes who has tested positive for this substance. The American athlete has received one of the shortest suspensions for LGD-4033.
Joane Orbon is the third American to test positive for LGD-4033. In 2016 Michael Buckley was suspended for four years, while Michael Gingras got a 12 year suspension for the same substance. Gingras - a coach in the sport of weightlifting - accepted a 12-year sanction for engaging in prohibited doping conduct.
First case in 2019
The suspension of Joan Orbon is the first sanction related to this substance in 2019. In 2016, the first year LGD-4033 first was detected, two athletes were suspended - an American cyclist and a Serbian body builder. In 2017 and 2018 there were four incidents related to the substance.
Facts regarding LGD-4033
LGD-4033 is an investigational selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis, discovered by Ligand Pharmaceuticals and currently under development by Viking Therapeutics. (Source: Wikipedia)